Bioequivalence Limit, Power and interpretation [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-09-22 13:27 (208 d 13:19 ago) – Posting: # 21930
Views: 1,101

Dear All,

I just want basic information about Bioequivalence limit with respect to power and number of subjects.
  1. What to conclude if we got the result where study is failed in lower side i.e. below 80%...
  2. What to conclude if we got the result where study is failed in upper side i.e. above 125%...
  3. What to conclude where study's post hoc power is less then 80 or 85%?

What are the main factors associated with apart from human or instrument error?

Thanks.

Dr. Pharma88

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 9 (0 registered, 9 guests [including 3 identified bots]).
Forum time: Monday 02:46 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5